In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic: Making Convergence Pay

Executive Summary

Medtronic has been a pioneer in drug/device convergence: creating products whose therapeutic benefit stems equally from the features of their drug and device components. Convergence represents one of the medical device industry's most promising opportunities. But getting past the cultural differences between medical device and biotech companies can be huge.
Advertisement

Related Content

Medtronic: Doing Just What the Doctors Order
Medtronic: Doing Just What the Doctors Order
Building Medtronic Neuro by Trial: An Interview with Richard Kuntz, MD
Medtronic: Ready to Deal Again
TCT Highlights: Late Stent Thrombosis Controversy Continues
Turning Around Medtronic Vascular
Medtronic Licenses Early Stage Stent Drug to Prevent Thrombosis
Gauging the Risks of Financing Convergence Start-Ups
Convergent Calling: An Interview with Medtronic's Stephen Oesterle
Convergent Calling: An Interview with Medtronic's Stephen Oesterle

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel